Anne Philomena Hyland
Corporate Officer/Principal presso London Stock Exchange Plc
Patrimonio netto: 41 529 $ in data 31/03/2024
Profilo
Anne Philomena Hyland is currently a Member-Primary Markets Group at London Stock Exchange Plc.
She previously worked as a Finance Director at Celltech Group Plc and Medeva Plc.
From 2010 to 2013, she was the CFO, Secretary & Executive Director at Vectura Group Ltd.
She also served as an Independent Non-Executive Director at Elementis Plc from 2013 to 2022 and at Clinigen Ltd.
from 2018 to 2022.
She was the Chief Financial Officer & Director at BBI Diagnostics Group 2 Plc and the Chief Financial Officer & Secretary at BBI Diagnostics Group Ltd.
She worked as an Audit Manager at KPMG Audit Plc.
From 2015 to 2021, she was the Chief Financial Officer & Secretary at Kymab Ltd.
She was a Trustee at Sustrans Ltd.
from 2012 to 2017.
Ms. Hyland received an undergraduate degree from Trinity College Dublin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ELEMENTIS PLC
0.00% | 06/03/2023 | 22 153 ( 0.00% ) | 41 529 $ | 31/03/2024 |
Posizioni attive di Anne Philomena Hyland
| Società | Posizione | Inizio |
|---|---|---|
London Stock Exchange Plc
 London Stock Exchange Plc Investment Banks/BrokersFinance London Stock Exchange Plc, operates as a stock exchange. It offers capital market, trading, information, derivatives, studio, regulatory, enhanced, connectivity, telephone network, reference and historical data, historic price, corporate action, trade data, valuation data, broker ranking, matching and reconciliation. The company was founded in 1571 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Precedenti posizioni note di Anne Philomena Hyland
| Società | Posizione | Fine |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Director/Board Member | 10/11/2022 |
| ELEMENTIS PLC | Director/Board Member | 26/04/2022 |
| CLINIGEN GROUP PLC | Director/Board Member | 01/04/2022 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 01/04/2021 |
Sustrans Ltd.
 Sustrans Ltd. Other Consumer ServicesConsumer Services Sustrans Ltd. operates as a charity that provides travel choices. It connects people and places, liveable neighbourhoods, transform the school run and delivers commute. The company was founded in 1977 and is headquartered in Bristol, the United Kingdom. | Director/Board Member | 01/01/2017 |
Formazione di Anne Philomena Hyland
| Trinity College Dublin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELEMENTIS PLC | Process Industries |
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| Aziende private | 10 |
|---|---|
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
BBI Diagnostics Group Ltd.
 BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
| Medeva Plc | Health Technology |
KPMG Audit Plc
 KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services KPMG Audit Plc provides accounting services. The company was founded in 1995 and is headquartered in London, GB. | Commercial Services |
London Stock Exchange Plc
London Stock Exchange Plc Investment Banks/BrokersFinance London Stock Exchange Plc, operates as a stock exchange. It offers capital market, trading, information, derivatives, studio, regulatory, enhanced, connectivity, telephone network, reference and historical data, historic price, corporate action, trade data, valuation data, broker ranking, matching and reconciliation. The company was founded in 1571 and is headquartered in London, the United Kingdom. | Finance |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Sustrans Ltd.
Sustrans Ltd. Other Consumer ServicesConsumer Services Sustrans Ltd. operates as a charity that provides travel choices. It connects people and places, liveable neighbourhoods, transform the school run and delivers commute. The company was founded in 1977 and is headquartered in Bristol, the United Kingdom. | Consumer Services |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom. | Commercial Services |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Health Services |
- Borsa valori
- Insiders
- Anne Philomena Hyland
